Avid Bioservices, Inc.
CDMO · NASDAQ
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | |
|---|---|---|---|---|
| Revenue | $139,911 | $149,266 | $119,597 | $95,868 |
| % Growth | -6.3% | 24.8% | 24.8% | – |
| Cost of Goods Sold | $132,593 | $117,786 | $82,949 | $66,561 |
| Gross Profit | $7,318 | $31,480 | $36,648 | $29,307 |
| % Margin | 5.2% | 21.1% | 30.6% | 30.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $25,196 | $27,179 | $20,626 | $16,764 |
| SG&A Expenses | $25,996 | $27,879 | $21,226 | $17,064 |
| Sales & Mktg Exp. | $800 | $700 | $600 | $300 |
| Other Operating Expenses | $0 | $0 | -$81 | $133 |
| Operating Expenses | $25,996 | $27,879 | $21,226 | $17,064 |
| Operating Income | -$18,678 | -$2,607 | $10,861 | $8,923 |
| % Margin | -13.3% | -1.7% | 9.1% | 9.3% |
| Other Income/Exp. Net | -$8,249 | -$2,011 | -$2,761 | -$1,031 |
| Pre-Tax Income | -$26,927 | $2,003 | $12,661 | $11,212 |
| Tax Expense | $113,826 | $1,443 | -$115,011 | $0 |
| Net Income | -$140,753 | $560 | $127,672 | $11,212 |
| % Margin | -100.6% | 0.4% | 106.8% | 11.7% |
| EPS | -2.23 | 0.009 | 2.08 | 0.057 |
| % Growth | -24,877.8% | -99.6% | 3,549.1% | – |
| EPS Diluted | -2.23 | 0.009 | 1.81 | 0.056 |
| Weighted Avg Shares Out | 63,199 | 62,268 | 61,484 | 58,222 |
| Weighted Avg Shares Out Dil | 63,199 | 63,782 | 70,474 | 59,426 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4,337 | $3,013 | $2,680 | $1,164 |
| Depreciation & Amortization | $11,109 | $7,210 | $4,480 | $3,453 |
| EBITDA | -$11,481 | $10,911 | $19,902 | $15,696 |
| % Margin | -8.2% | 7.3% | 16.6% | 16.4% |